# Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer

> **NCT01317199** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 143 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Muscadine Plus Grape Skin Extract
- **DRUG:** Low-dose MPX
- **DRUG:** High-dose MPX
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT01317199
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2021-04-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01317199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01317199, "Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01317199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*